7

The Cigna Corporation (NYSE:CI) is going down by -0.87% in today’s trading session, a fall equivalent to -1.72% of the stock’s price from yesterday’s market close. A news came out on 11/25/19 stating that Cigna and the Cigna Foundation Help Improve Health and Well-being of Unpaid Family Caregivers in Massachusetts by WSJ. The lowest point that the shares touched during the trading session was $196.84, while the peak of the day was recorded at a share price of $200.39. CI finished the previous session at $196.94 according to the data provided by Barchart, while the trading volume was observed to be $680269.

In the 100 days of trading, CI managed to top a 168.94% Moving average. Additionally, Cigna Corporation shares have achieved a 52-week range between 141.95 and 226.60 alongside 100 days raw stochastic set at 83.74%.

The number of shares outstanding, according to the fundamentals of the company, is set at 373.63M, equal to the value of $73.58B in market capitalization. In the last 30 days, Cigna Corporation shares went down by -4.73%, adding 205.24 to growth in value, on top of a +9.57% boost since 11/01/19.

Cigna Corporation (NYSE:CI) Analyst’s Estimates

Cigna Corporation (CI) could record at least $4.20 per share in quarterly earnings in the upcoming report on 02/06/2020, a number that would actually represent an increase of 18.57 YOY.

According to the average analyst rating, Cigna Corporation would be rated as Buy. Out of 26 different analysts monitoring CI stock, 20 analysts rate the stock as a BUY, 3 suggest to give the rating of HOLD, 3 indicate that CI is an OVERWEIGHT, 0 rated the stock as a SELL, and 0 analyst believes that the stock should be rated as UNDERWEIGHT.

On October 18, 2019, the stock earned a Initiated rating due to a new analyst call from Mizuho, while analysts from BMO Capital Markets believe that the stock is set at Outperform from Market Perform, as concluded on September 30, 2019. Deutsche Bank, is still rather wary about the stock, deciding to keep the rating at Buy as confirmed through a call on September 12, 2019.

Regardless of the rating, Bernstein did increase their price to $205 as they are considering target share price analysis. UBS, on the other hand, provided a rather enthusiastic opinion on the rating, concluded in an analyst call on April 23, 2019, giving the stock a Buy rating.

CI Key Ratios To Watch:

Taking in account the profitability of the Company, the operating margin has been recorded at +10.28. The firm is also showcasing profitability through returns on assets in the company’s ownership, with ROA set at 2.43%. Beta value of the stock is recorded at 0.76. Additionally, Cigna Corporation is recording price volatility of 1.84% for the period of the last seven days and 2.20% in the last 30 days.

Cigna Corporation (NYSE:CI) Technical Outlook

For the period of the last 50 days, Cigna Corporation had its Raw Stochastic average set at 83.47% for the latest technical analysis. In comparison to the period of the last 20 days, the present Raw Stochastic average for the last 50 days poses as improvement, set at 58.79%. Stochastic %K for Cigna Corporation, with the last 20 days included, was set at 69.42%, having Stochastic %D topping 76.86%. Based on the previous performance of the company for the mentioned period, there are more than several recorded moving trends. When it comes to the period of the last 12 months, accounting the time for year-to-date, price performance appears to be encouraging for Cigna Corporation stocks with recording 3.70% in metrics.

Cigna Corporation Insider Watch:

Similarly, 91.76% of the company’s float is held by institutions – and there are 1,557 institutions in total holding shares of this company. The top three institutional holders of CI stocks are: Vanguard Group, Inc. (The) with ownership of $4.37 billion, which is approximately 28758645 of the company’s shares; Blackrock Inc., holding 25877020 shares of the stock with an approximate value of $3.93 billion; and Price (T.Rowe) Associates Inc, currently with more than 23847058 shares of the company valued at $3.62 billion. Positions in Cigna Corporation stocks held by institutional investors has been changing actively in the past six months, a period during which there were 41 insider purchases amounting to 90855 shares. Similarly, there were 6 sale transactions amounting to 28820 shares, with the net shares purchased during the last six months reaching 62,035.

Advertisement